Workflow
医药商业板块9月17日涨0.17%,XD益丰药领涨,主力资金净流出2.25亿元
Zheng Xing Xing Ye Ri Bao·2025-09-17 08:45

Market Performance - The pharmaceutical commercial sector increased by 0.17% compared to the previous trading day, with XD Yifeng Pharmaceutical leading the gains [1] - The Shanghai Composite Index closed at 3876.34, up 0.37%, while the Shenzhen Component Index closed at 13215.46, up 1.16% [1] Stock Performance - Key stocks in the pharmaceutical commercial sector showed varied performance, with XD Yifeng Pharmaceutical closing at 26.22, up 2.66%, and Dazhenglin at 17.66, up 2.56% [1] - Other notable performers included Liuyao Group at 18.90, up 1.02%, and China Pharmaceutical at 10.95, up 0.83% [1] Trading Volume and Value - XD Yifeng Pharmaceutical had a trading volume of 106,700 shares and a transaction value of 279 million yuan [1] - Dazhenglin recorded a trading volume of 72,200 shares with a transaction value of 126 million yuan [1] Capital Flow - The pharmaceutical commercial sector experienced a net outflow of 225 million yuan from institutional investors, while retail investors saw a net inflow of 205 million yuan [2] - Speculative funds had a net inflow of approximately 19.83 million yuan [2] Individual Stock Capital Flow - China Pharmaceutical had a net inflow of 20.91 million yuan from institutional investors, while it faced a net outflow of 8.68 million yuan from retail investors [3] - Liuyao Group saw a net inflow of 7.14 million yuan from institutional investors, but a net outflow of 10.03 million yuan from retail investors [3]